Akihiko Suto

1.3k total citations
63 papers, 945 citations indexed

About

Akihiko Suto is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Akihiko Suto has authored 63 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 28 papers in Cancer Research and 13 papers in Molecular Biology. Recurrent topics in Akihiko Suto's work include Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (12 papers) and Breast Lesions and Carcinomas (11 papers). Akihiko Suto is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), HER2/EGFR in Cancer Research (12 papers) and Breast Lesions and Carcinomas (11 papers). Akihiko Suto collaborates with scholars based in Japan, United States and United Kingdom. Akihiko Suto's co-authors include Nitin Telang, H. Leon Bradlow, George Y. Wong, Michael P. Osborne, Tetsuro Kubota, Kyuya Ishibiki, Shin Takayama, Sho Shiino, Osahiko Abe and Masaki Kitajima and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Akihiko Suto

58 papers receiving 889 citations

Peers

Akihiko Suto
Akihiko Suto
Citations per year, relative to Akihiko Suto Akihiko Suto (= 1×) peers Adam Maciejczyk

Countries citing papers authored by Akihiko Suto

Since Specialization
Citations

This map shows the geographic impact of Akihiko Suto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Suto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Suto more than expected).

Fields of papers citing papers by Akihiko Suto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiko Suto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Suto. The network helps show where Akihiko Suto may publish in the future.

Co-authorship network of co-authors of Akihiko Suto

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiko Suto. A scholar is included among the top collaborators of Akihiko Suto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiko Suto. Akihiko Suto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kitajima, Kazuhiro, Yasuo Miyoshi, Tetsuro Sekine, et al.. (2024). Harmonized pretreatment quantitative volume-based 18F-FDG PET/CT parameters for stage IV breast cancer prognosis. Multicenter study in Japan.. PubMed. 23(3). 272–289.
2.
Sasada, Shinsuke, Naoto Kondo, Hiroya Hashimoto, et al.. (2023). Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer. Breast Cancer Research and Treatment. 202(3). 473–483. 2 indexed citations
3.
Takayama, Shin, Takayuki Kinoshita, Sho Shiino, et al.. (2023). Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services. JMA Journal. 6(4). 505–512. 2 indexed citations
5.
Shimoi, Tatsunori, Ayumi Saito, Yuki Kojima, et al.. (2023). Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(6). 855–863. 5 indexed citations
6.
Nakayama, Jun, Marta Prieto‐Vila, Sho Shiino, et al.. (2022). Single-Cell Transcriptome Profiling Reveals Intratumoral Heterogeneity and Molecular Features of Ductal Carcinoma In Situ. Cancer Research. 82(18). 3236–3248. 18 indexed citations
7.
Takayama, Shin, et al.. (2022). Clinical Application of MicroRNAs in Breast Cancer Treatment. SHILAP Revista de lepidopterología. 20–31. 2 indexed citations
8.
Yazaki, Shu, Roberto Salgado, Tatsunori Shimoi, et al.. (2022). Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer. British Journal of Cancer. 128(4). 568–575. 9 indexed citations
9.
Shimomura, Akihiko, Masayuki Yoshida, Takashi Kubo, et al.. (2022). Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer. Breast Cancer Research and Treatment. 197(3). 593–602.
10.
Ochi, Eisuke, Katsunori Tsuji, Yoichi Shimizu, et al.. (2021). Cardiorespiratory fitness in breast cancer survivors: a randomised controlled trial of home-based smartphone supported high intensity interval training. BMJ Supportive & Palliative Care. 12(1). 33–37. 33 indexed citations
11.
Takayama, Shin, Masayuki Yoshida, Sho Shiino, et al.. (2021). A case of lymph node dissection for contralateral axillary lymph node metastasis of ipsilateral breast tumor recurrence after identifying the primary lymphatic drainage by lymphoscintigraphy. International Cancer Conference Journal. 10(2). 154–158. 1 indexed citations
12.
Ohno, Shinji, Hirofumi Mukai, Kazutaka Narui, et al.. (2019). Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study. Breast Cancer Research and Treatment. 176(3). 631–635. 4 indexed citations
13.
Kijima, Hiroshi, Akihiko Suto, Toshio Takeshita, et al.. (1999). Gallbladder Carcinoma With Lymphoid Stroma. Journal of Clinical Gastroenterology. 28(3). 256–258. 5 indexed citations
14.
Kijima, Hiroshi, et al.. (1999). Carcinosarcoma of The Ampulla of Vater: A Case Report With Immunohistochemical and Ultrastructural Studies. The American Journal of Gastroenterology. 94(10). 3055–3059. 23 indexed citations
15.
Saikawa, Yoshiro, et al.. (1994). Single‐cell Suspension Assay with an MTT End Point Is Useful for Evaluating the Optimal Adjuvant Chemotherapy for Advanced Gastric Cancer. Japanese Journal of Cancer Research. 85(7). 762–765. 31 indexed citations
16.
Suto, Akihiko, H. Leon Bradlow, George Y. Wong, Michael P. Osborne, & Nitin Telang. (1993). Experimental down-regulation of intermediate biomarkers of carcinogenesis in mouse mammary epithelial cells. Breast Cancer Research and Treatment. 27(3). 193–202. 53 indexed citations
17.
Telang, Nitin, Akihiko Suto, H. Leon Bradlow, George Y. Wong, & Michael P. Osborne. (1993). Genotoxic Damage and Aberrant Proliferation in Mouse Mammary Epithelial Cells. PubMed. 48. 481–488. 12 indexed citations
18.
Suto, Akihiko. (1991). The influence of stromal cells on the MTT assay (II)—Study on the nude mouse system—. Surgery Today. 21(3). 308–311. 1 indexed citations
19.
Kubota, Tetsuro, Shin Fujita, Susumu Kodaira, et al.. (1991). Antitumor Activity of Fluoropyrimidines and Thymidylate Synthetase Inhibition. Japanese Journal of Cancer Research. 82(4). 476–482. 31 indexed citations
20.
Furukawa, Toshiharu, Tetsuro Kubota, Akihiko Suto, et al.. (1991). Clinical usefulness of chemosensitivity testing using the MTT assay. Journal of Surgical Oncology. 48(3). 188–193. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026